Feng Chi Biotech Corp. (TPEX:6744)
Taiwan · Delayed Price · Currency is TWD 15.70
-0.40 (-2.48%)
Jul 21, 2026, 9:37 AM CST
Feng Chi Biotech Market Cap
Feng Chi Biotech has a market cap or net worth of 247.94 million as of July 21, 2026. Its market cap has decreased by -19.10% in one year.
Market Cap
247.94M
Enterprise Value
75.24M
Revenue
177.36M
Ranking
n/a
PE Ratio
17.13
Stock Price
15.70
ChartMarket Cap Chart
Since September 25, 2019, Feng Chi Biotech's market cap has decreased from 742.28M to 247.94M, a decrease of -66.60%. That is a compound annual growth rate of -14.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 247.94M | -9.55% |
| Dec 31, 2025 | 274.12M | -10.10% |
| Dec 30, 2024 | 304.92M | -10.81% |
| Dec 29, 2023 | 341.88M | 11.00% |
| Dec 29, 2022 | 308.00M | -19.19% |
| Dec 28, 2021 | 381.15M | -16.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Taiwan Advance Bio-Pharmaceutical | 890.10M |
| NatureWise Biotech & Medicals | 800.93M |
| BioLASCO Taiwan | 761.96M |
| Neith | 710.20M |
| MegaPro Biomedical | 692.51M |
| SynCore Biotechnology Co.,Ltd | 685.71M |
| Vectorite Biomedical | 617.18M |
| TaiwanJ Pharmaceuticals | 552.84M |